Earlier this month, the Obama administration appealed [JURIST report] the injunction, arguing that Lamberth's ruling was overbroad, endangering an array of research across multiple programs and centers while only serving a very attenuated economic interest of the plaintiffs in the case. According to the filing, the injunction threatens 24 research projects, more than 1,300 jobs and $64 million in funding, as well as potentially millions of Americans who may benefit from medical advances in the field of stem cell research. Last year, President Barack Obama signed an executive order [JURIST report] permitting federal funding for some forms of embryonic stem cell research. Despite the executive order, Lambert held that evidence showed that the plaintiffs were substantially likely to prevail based on existing law.